Status:
RECRUITING
Fibro-inflammatory Progression From Acute to Chronic Pancreatitis
Lead Sponsor:
Copenhagen University Hospital, Hvidovre
Conditions:
Pancreatitis
Acute Pancreatitis
Eligibility:
All Genders
18-70 years
Brief Summary
Observational prospective study evaluating the developement of chronic pancreatitis based on imaging modalities as well as biochemical markers of inflammation, fibrosis and oxidative stress.
Detailed Description
Chronic pancreatitis (CP) represents the end-stage of a continuous disease process evolving from acute pancreatitis (AP), over recurrent acute pancreatitis (RAP). Due to the irreversible nature of CP,...
Eligibility Criteria
Inclusion
- Patients with CP (N=50) of any aetiology except gallstone induced CP: CP will be diagnosed based on MANNHEIM criteria .
- Cohort 2: Patients with their first attack of AP of any aetiology except gallstone induced AP (N=50). The revised Atlanta criteria for acute pancreatitis will be used as diagnostic criteria.
- Cohort 3: Patients with RAP (N=50) except gallstone induced RAP. RAP is defined as two or more cases of AP as diagnosed by the revised Atlanta Criteria.
Exclusion
Key Trial Info
Start Date :
February 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2041
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03853447
Start Date
February 14 2019
End Date
January 1 2041
Last Update
April 8 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Gastrounit, Copenhagen University Hospital Hvidovre
Hvidovre, Capital Region Denmark, Denmark, 2650
2
Department of Gastroenterology & Hepatology, Aalborg University Hospital
Aalborg, Denmark, 9000
3
Abdominal Centre, Bispebjerg University Hospital
Copenhagen, Denmark, 2200